Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
1 NEW September 25, 2023
Could a prostate cancer drug save lives from radiation injury?

Could a prostate cancer drug save lives from radiation injury?

Early research shows potential for approved hormone-blocking drug to protect from deadly effects of nuclear blast
Hutch NewsJanuary 09, 2018
Dr. Hans-Peter Kiem

Dr. Hans-Peter Kiem

<p>'He really wanted to fight this cancer': A stem cell researcher remembers his first patient in a gene therapy clinical trial
Hutch NewsFebruary 24, 2016
Dramatic remissions seen in immunotherapy trial of blood cancer patients

Dramatic remissions seen in immunotherapy trial of blood cancer patients

Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care
Hutch NewsFebruary 16, 2016
‘The successes kept you going’: 40 years of bone marrow transplantation

‘The successes kept you going’: 40 years of bone marrow transplantation

On the eve of ‘Emperor’ cancer documentary, Dr. Fred Appelbaum recounts 40 years of difficult and exhilarating advances in bone marrow transplantation
Hutch NewsMarch 27, 2015
Beyond blood drives: Stem cell donors help fuel scientific discovery

Beyond blood drives: Stem cell donors help fuel scientific discovery

Volunteers for the little-known procedures earn up to $800 – and the chance to contribute to cutting-edge research
Hutch NewsOctober 31, 2014
Transplanted stem cell 'shield' helps brain cancer patients

Transplanted stem cell 'shield' helps brain cancer patients

Hans-Peter Kiem study is first to show patients' own gene-modified blood stem cells can protect bone marrow from chemotherapy toxicity
Hutch NewsMay 14, 2012
Modified marrow cells may resist chemotherapy’s toxic effects

Modified marrow cells may resist chemotherapy’s toxic effects

Hans-Peter Kiem and colleagues find chemo-resistant genes may enable safer, more effective treatment for brain cancer patients
Hutch NewsMay 23, 2011
For the First Time a Molecular Test Proves to be Effective in Measuring the Extent of Remission After Cancer Treatment and the Potential for Relapse

For the First Time a Molecular Test Proves to be Effective in Measuring the Extent of Remission After Cancer Treatment and the Potential for Relapse

The molecular test is already saving lives of patients who relapse after bone-marrow or stem-cell transplantation. Researchers now predict that the approach will speed the delivery of promising new therapies to other patients
News ReleasesOctober 08, 2003
Study Raises Doubt About the Notion of Adult Stem Cell Plasticity

Study Raises Doubt About the Notion of Adult Stem Cell Plasticity

Adult stem cells from bone marrow fail to generate stromal cells after hematopoietic cell transplantation
News ReleasesAugust 05, 2002